Combining Selinexor with R-CHOP in the Treatment of Newly Diagnosed High-Risk (IPI 35) GCB Subtype DLBCL Patients: A Multicenter, Open Label Phase 2 StudyZhiming Li,Hang Yang,Yanxue Yin, Yajun Li,Xue Gao,Peng Sun, Yu Wang,Lu Zhang,Hui Zhou,Keshu Zhou,Jay MeiBLOOD（2023）引用 0|浏览39AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
